(Q34150929)

31 July 2017

Effects of tuberculosis, race, and human gene SLCO1B1 polymorphisms on rifampin concentrations (English)

1 reference

31 July 2017

0 references

1 reference

Marc Weiner

1

1 reference

31 July 2017

Charles Peloquin

2

1 reference

31 July 2017

William Burman

3

1 reference

31 July 2017

Chi-Cheng Luo

4

1 reference

31 July 2017

Melissa Engle

5

1 reference

31 July 2017

Thomas J Prihoda

6

1 reference

31 July 2017

William R Mac Kenzie

7

1 reference

31 July 2017

Erin Bliven-Sizemore

8

1 reference

31 July 2017

John L Johnson

9

1 reference

31 July 2017

Andrew Vernon

10

1 reference

31 July 2017

language of work or name

English

0 references

publication date

26 July 2010

1 reference

Antimicrobial Agents and Chemotherapy

31 July 2017

1 reference

31 July 2017

54

1 reference

31 July 2017

10

1 reference

31 July 2017

4192-4200

1 reference

Effects of rifampin and multidrug resistance gene polymorphism on concentrations of moxifloxacin

31 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944564

Intestinal drug transporter expression and the impact of grapefruit juice in humans

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944564

Dosing schedules of 6-month regimens and relapse for pulmonary tuberculosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944564

Potent twice-weekly rifapentine-containing regimens in murine tuberculosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944564

Determinants of rifampin, isoniazid, pyrazinamide, and ethambutol pharmacokinetics in a cohort of tuberculosis patients

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944564

Serum concentrations of antimycobacterial drugs in patients with pulmonary tuberculosis in Botswana

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944564

Detection of MDR1 single nucleotide polymorphisms C3435T and G2677T using real-time polymerase chain reaction: MDR1 single nucleotide polymorphism genotyping assay

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944564

Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944564

Low plasma concentrations of rifampicin in tuberculosis patients in Indonesia.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944564

Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944564

Rifampicin bioavailability: a review of its pharmacology and the chemotherapeutic necessity for ensuring optimal absorption

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944564

Pharmacokinetics of rifampin under fasting conditions, with food, and with antacids

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944564

Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944564

Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944564

Rifampicin alters atorvastatin plasma concentration on the basis of SLCO1B1 521T>C polymorphism

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944564

effect of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944564

Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944564

Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944564

Association between acquired rifamycin resistance and the pharmacokinetics of rifabutin and isoniazid among patients with HIV and tuberculosis

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944564

Effect of sex and AIDS status on the plasma and intrapulmonary pharmacokinetics of rifampicin

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944564

Pharmacokinetics-pharmacodynamics of rifampin in an aerosol infection model of tuberculosis

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944564

Pharmacokinetics of antimycobacterial drugs in patients with tuberculosis, AIDS, and diarrhea

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944564

Bioavailability of rifampicin capsules.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944564

Drug combinations and the bioavailability of rifampicin

28 October 2018

1 reference

12 December 2020

Pharmacokinetic study of the interaction between rifampin and delavirdine mesylate

1 reference

12 December 2020

Rifampin and rifabutin and their metabolism by human liver esterases

1 reference

12 December 2020

Regional levels of drug transporters along the human intestinal tract: co-expression of ABC and SLC transporters and comparison with Caco-2 cells

1 reference

12 December 2020

Intestinal permeability and malabsorption of rifampin and isoniazid in active pulmonary tuberculosis

1 reference

12 December 2020

India's trade in fake drugs--bringing the counterfeiters to book

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.00353-10

1 reference

31 July 2017

1 reference

31 July 2017

1 reference